Nomogram for predicting the biochemical recurrence of prostate cancer after neoadjuvant androgen deprivation therapy
ConclusionsWe constructed and validated a nomogram to predict the risk of BCR in PCa patients after nADT. This nomogram is a complement to the existing risk stratification systems for PCa, which could have marked implications for clinical decision-making for PCa patients after nADT.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Cancer | Cancer & Oncology | Neoadjuvant Therapy | Pathology | Prostate Cancer | Prostatectomy | Study | Urology & Nephrology